Phosphorus Disorders and Refeeding Syndrome Integration

Mechanism

Severe hypophosphatemia

Defined as a plasma phosphorus concentration less than 1.0 mg/dL. Its severe decrease causes profound depletion of cellular ATP and alters the synthesis of the compound 2,3-diphosphoglycerate (2,3-DPG) in erythrocytes, which increases the affinity of hemoglobin for oxygen, blocking its delivery to peripheral target tissues.

Security

Safety Alert: Refeeding Syndrome

Refeeding syndrome is a potentially fatal hydroelectrolyte complication that occurs after the abrupt introduction of nutritional support (enteral or parenteral) in patients who have suffered prolonged periods of severe malnutrition, chronic fasting, alcoholism or anorexia nervosa.

Pathophysiology of the Anabolic Transition:

1. During prolonged fasting, the body predominantly metabolizes lipids and ketone bodies, depleting total body reserves of phosphates, potassium and thiamine, although maintaining normal or falsely borderline serum levels.
2. When carbohydrate intake begins, the release of insulin is triggered abruptly to facilitate glucose uptake.
3. The elevation of insulin immediately stimulates the intracellular uptake of glucose, phosphorus, potassium and cellular water. As a consequence, the few remaining serum concentrations of phosphorus are rushed into the cell, causing a catastrophic drop in extracellular phosphorus in the first 24-72 hours after nutrition begins.

This metabolic collapse can induce lethal arrhythmias, multiple organ failure and arrest in asystole. It should be prevented by identifying high-risk patients, administering exogenous thiamine supplements (100-300 mg/day) and reducing the initial caloric intake to 50% of basal requirements, performing phosphorus determinations every 12 hours.

Clinical

Clinical Manifestations of Collapse due to Hypophosphatemia

Systemic energy depletion due to lack of intracellular phosphorus is manifested by:

• Acute skeletal myopathy and imminent risk of fulminant rhabdomyolysis.
• Restrictive diaphragmatic dysfunction, systematically making it impossible to successfully wean the patient on invasive mechanical ventilation in the ICU.
• Diffuse metabolic encephalopathy, generalized paresthesias and reversible acute myocardial failure.